RSV and the 'tripledemic'

A recent increase of Respiratory Syncytial Virus (RSV), a contagious respiratory virus that affects the lungs and breathing passages, among young children in the United States has sparked a discussion about the possibility of RSV, COVID-19, and influenza to create a ‘tripledemic’ this winter.  Although vaccines are available for COVID-19 and the Influenza virus, there are no vaccines available for RSV, making preventative measures essential to decreasing the spread of RSV. 

Who does RSV most affect?

• RSV can cause severe infection in babies 12 months and younger, older adults, people with heart and lung disease, or individuals who are immunocompromised. 

How is RSV spread?

• RSV is spread through the droplets produced when an infected person coughs or sneezes. The virus can live on surfaces for a few hours, and can also be spread when a person touches the contaminated surface. 

What are the symptoms of RSV?

• The symptoms of RSV, COVID-19, and the flu can look very similar in children and young adults. Symptoms include: 
  • Congestion.
  • Cough.
  • Runny nose.
  • Muscle aches.
  • Fever.
  • Headache.

How severe is RSV?

• Most people recover from RSV within one to two weeks, although younger children and older adults are more likely to face severe cases of RSV. ​​RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children younger than 1 year of age in the United States.

How long is someone contagious with RSV?

• Two to eight days following exposure, an individual is typically contagious and can spread RSV to others for an additional three to eight days. 

What precautions should I take to avoid getting RSV?

• Covering your coughs and sneezes, frequently washing your hands, wearing a mask, and avoiding close contact with others who are sick can greatly reduce the potential of contracting RSV. These precautions also help fight against the spread of COVID-19 and Influenza virus!